Patents by Inventor Keno Ishihara

Keno Ishihara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Water Soluble Silicon-Containing Granulate
    Publication number: 20210393528
    Abstract: A water-soluble silicon-containing granulate comprising a silicon compound of the formula YxSi(OH)4-x or an oligomer thereof, wherein Y is optionally substituted (C1-C4)alkyl, (C2-C5)-alkenyl, (C1-C4)-alkoxy, amino, and wherein x is 0-2, and a cold-water soluble starch material.
    Type: Application
    Filed: November 19, 2019
    Publication date: December 23, 2021
    Inventors: Mario Remi Yvonne Calomme, Keno Ishihara, Masako Okabe, Richard Alan Passwater
  • Method for angiogenesis inhibition or immunostimulation
    Patent number: 7977379
    Abstract: The present invention relates to a composition for use in prevention or treatment of a vascular-related disease, particularly used for angiogenesis inhibition, tumor growth inhibition or tumor metastasis inhibition, or immunostimulation, which comprises glutamic acid or derivatives thereof, preferably glutamic acid is anhydrous glutamic acid represented by Formula (1) or pyroglutamic acid, and a pharmaceutically acceptable carrier or an edible carrier, and a method of preventing or treating a vascular-related disease.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: July 12, 2011
    Assignee: BHN Co., Ltd.
    Inventors: Takashi Kouge, Akihiro Yamashita, Keno Ishihara
  • Composition for use in prevention or treatment of vascular-related diseases
    Publication number: 20040029955
    Abstract: The present invention relates to a composition for use in prevention or treatment of a vascular-related disease, particularly used for angiogenesis inhibition, tumor growth inhibition or tumor metastasis inhibition, or immunostimulation, which comprises glutamic acid or derivatives thereof, preferably glutamic acid is anhydrous glutamic acid represented by Formula (1) or pyroglutamic acid, and a pharmaceutically acceptable carrier or an edible carrier, and a method of preventing or treating a vascular-related disease.
    Type: Application
    Filed: May 15, 2003
    Publication date: February 12, 2004
    Inventors: Takashi Kouge, Akihiro Yamashita, Keno Ishihara